{"nct_id":"NCT01189422","title":"Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes","status":"TERMINATED","status_verified_date":"2022-02","start_date":"2010-08","start_date_type":null,"primary_completion_date":"2011-02","primary_completion_date_type":"ACTUAL","completion_date":"2011-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MGNX"]}